Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
follitropin beta 300 IE injektionsvæske, opløsning, cylinderampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
follitropin beta 600 IE injektionsvæske, opløsning, cylinderampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
Pituitary follicle stimulating hormone-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
Somatropin [2] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
follitropin alfa 600 enheder/ml injektionsvæske, opløsning i fyldt pen a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
rekombinant humant follikelstimulerende hormon alfa 450 IE pulver til injektionsvæske, rekonstitution + solvens |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
rekombinant humant follikelstimulerende hormon alfa 1050 IE pulver til injektionsvæske, rekonstitution + solvens |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
Product containing precisely somatrem 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
Somatrem 10 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
follitropin beta 75 IE/pulver, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
follitropin alfa 150 enheder pulver til injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
follitropin alfa 75 IE/ampul, pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
somatropin 10 mg hætteglas opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
somatropin 10 mg/2 ml opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
somatropin 1,6 mg pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
somatropin 1,2 mg pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
somatropin 2 mg pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
somatropin 0,8 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
somatropin 2,0 mg/0,25 ml pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
somatropin 13,8 mg pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
Somatropin 1.5mg powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
somatropin 1,4 mg pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
somatropin 0,2 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
Somatropin 5.8mg powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
somatropin 1,4 mg/0,25 ml pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
somatropin 1,6 mg/0,25 ml pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
somatropin 1,2 mg/0,25 ml pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
somatropin 0,8 mg/enhed pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
somatropin 0,6 mg/enhed pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
somatropin 1,8 mg pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
somatropin 0,44 mg/enhed pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
somatropin 1,8 mg/0,25 ml pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
somatropin 1,0 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
somatropin 0,4 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
Pituitary follicle stimulating hormone 75 unit and pituitary luteinizing hormone 75 unit powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
Pituitary follicle stimulating hormone 150 unit and pituitary luteinizing hormone 150 unit powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
Product containing anterior pituitary hormone (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
follitropin beta 900 IE injektionsvæske, opløsning, cylinderampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
rekombinant humant follikelstimulerende hormon alfa 1200 IE pulver og solvens til injektionsvæske, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
cosyntropin 50 µg + mannitol 10 mg injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
sermorelinacetat 0,5 mg pulver til injektionsvæske, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
somatropin 12 mg pulver til injektionsvæske, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
somatropin 0,6 mg pulver til injektionsvæske, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
somatropin 15 mg/1,5 ml injektionsvæske, opløsning, cylinderampul a 1,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
somatropin 5,0 mg/1,5 ml injektionsvæske, opløsning, cylinderampul a 1,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
sermorelinacetat 1,0 mg pulver til injektionsvæske, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
somatropin 5 mg pulver til injektionsvæske, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
somatropin 10 mg pulver til injektionsvæske, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
somatropin 6 mg pulver til injektionsvæske, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
sermorelinacetat 50 µg pulver til injektionsvæske, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
somatropin 10,0 mg/1,5 ml injektionsvæske, opløsning, cylinderampul a 1,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
Anterior pituitary hormone |
Is a |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
Poisoning by pituitary hormone |
Causative agent |
True |
Pituitary hormone |
Inferred relationship |
Some |
1 |
Anterior pituitary hormone |
Is a |
True |
Pituitary hormone |
Inferred relationship |
Some |
|
Allergy to pituitary hormone (finding) |
Causative agent |
True |
Pituitary hormone |
Inferred relationship |
Some |
1 |
corticotropt middel |
Is a |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
forgiftning med somatotropin, uvist med hvilken hensigt |
Causative agent |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
Melanocyte stimulating hormone analog (substance) |
Is a |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
Prolactin |
Is a |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
Human follicle stimulating hormone (substance) |
Is a |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
forgiftning med somatotropin |
Causative agent |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
Intentional thyrotrophic hormone poisoning |
Causative agent |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
accidentel forgiftning med somatropin |
Causative agent |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
tilsigtet forgiftning med somatotropin |
Causative agent |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
Thyrotrophic hormone poisoning |
Causative agent |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
Accidental thyrotrophic hormone poisoning |
Causative agent |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
forgiftning med thyroideastimulerende hormon, uvist med hvilken hensigt |
Causative agent |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
Human menopausal gonadotropin |
Is a |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
Poisoning by anterior pituitary hormone |
Causative agent |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
Pituitary follicle stimulating hormone |
Is a |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
Lipotropin |
Is a |
False |
Pituitary hormone |
Inferred relationship |
Some |
|